These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7605505)

  • 1. About diminished transport of maternal IgG (RhD alloimmunization) to the fetus.
    Grozdea J; Alie-Daram S; Vergnes H; Brisson-Lougarre A; Calot M; Martin J; Fournie A
    Vox Sang; 1995; 68(2):134-5. PubMed ID: 7605505
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhD alloimmunization without apparent exposure to RhD antigen.
    Kudva GC; Branson KD; Grossman BJ
    Am J Hematol; 2006 Mar; 81(3):218. PubMed ID: 16493600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn.
    Alie-Daran SJ; Dugoujon JM; Fournie A
    Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-anti-D antibodies in red-cell alloimmunization.
    Lobo GA; Nardozza LM; Camano L
    Int J Gynaecol Obstet; 2006 Aug; 94(2):139-40. PubMed ID: 16828096
    [No Abstract]   [Full Text] [Related]  

  • 10. RhD blocking phenomenon implicated in an immunohaematological diagnostic dilemma in a case of RhD-haemolytic disease of the foetus.
    Verma A; Sachan D; Bajpayee A; Elhence P; Dubey A; Pradhan M
    Blood Transfus; 2013 Jan; 11(1):140-2. PubMed ID: 22790265
    [No Abstract]   [Full Text] [Related]  

  • 11. Rh(D) alloimmunization in the absence of exposure to Rh(D) antigen.
    Biggins KR; Bowman JM
    Vox Sang; 1986; 51(3):228-30. PubMed ID: 3101288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of maternal isoimmunization to RhD antigen].
    Baptista González HA; Rosenfeld Mann F
    Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858
    [No Abstract]   [Full Text] [Related]  

  • 13. Flow cytometric quantitation of serum anti-D in pregnancy.
    Christensson M; Bremme K; Shanwell A; Westgren M; Christensson B
    Transfusion; 1996 Jun; 36(6):500-5. PubMed ID: 8669080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and molecular analyses of a patient with anti-G and anti-D due to alloimmunisation during her pregnancy.
    Chen Q; Xiao J; Huang C; Li M; Yao G
    Blood Transfus; 2015 Jul; 13(3):533-4. PubMed ID: 25761315
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and treatment of anti-D in pregnancy.
    Bettelheim D; Panzer S; Reesink HW; Csapo B; Pessoa C; Guerra F; Wendel S; Calda P; Sprogøe U; Dziegiel M; Aitokallio-Tallberg A; Koskinen S; Kuosmanen M; Legler TJ; Stein W; Villa S; Villa MA; Trespidi L; Acaia B; Vandenbussche FP; Brand A; de Haas M; Kanhai HH; Gounder D; Flanagan P; Donegan R; Parry E; Sefonte C; Skulstad SM; Hervig T; Flesland Ø; Zupańska B; Uhrynowska M; Lapaire O; Zhong XY; Holzgreve W
    Vox Sang; 2010 Aug; 99(2):177-92. PubMed ID: 20331536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange and high-dose i.v. immunoglobulin in the treatment of severe rhesus hemolytic disease.
    Berlin G; Selbing A; Gottvall T
    Prog Clin Biol Res; 1990; 337():337-40. PubMed ID: 2112753
    [No Abstract]   [Full Text] [Related]  

  • 18. Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn.
    Palfi M; Hildén JO; Gottvall T; Selbing A
    Am J Reprod Immunol; 1998 May; 39(5):323-8. PubMed ID: 9602250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study.
    Walsh CA; Doyle B; Quigley J; McAuliffe FM; Fitzgerald J; Mahony R; Higgins S; Carroll S; McParland P
    Ultrasound Obstet Gynecol; 2014 Dec; 44(6):669-73. PubMed ID: 24706487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological testing during pregnancy in women given routine antenatal anti-D Ig prophylaxis.
    de Silva PM; Knight RC
    Transfus Med; 1997 Dec; 7(4):323-4. PubMed ID: 9510934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.